Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.187
Neutral
RSI(14)
48.653
Neutral
STOCH(KDJ)(9,3,3)
58.501
Buy
ATR(14)
2.442
High Vlolatility
CCI(14)
114.635
Buy
Williams %R
16.564
Overbought
TRIX(12,20)
-0.284
Sell
StochRSI(14)
100.000
Buy
Search
Zoetis Inc
ZTSAdd to Watchlist
77.860USD
+0.950+1.24%
Market hours （ET）Quotes delayed by 15 min
32.73BMarket Cap
12.89P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+1.11%
5 Days
+3.58%
1 Month
-1.97%
6 Months
-37.61%
Year to Date
-38.19%
1 Year
-48.68%
Key Figures
77.245Open
78.050High
497.20KVolume
12.89P/E TTM
10.80P/E Dynamic
2.060Dividend TTM
0.12%Turnover Ratio
76.910Prev. Close
76.650Low
16.37MTurnover
13.17P/E Static
10.12P/B
2.65%Div Yield TTM
18.07%ROA
172.23052wk High
1.21Volume Ratio
2.49BNet Profit
420.35MShares
6.0419EPS TTM
0.77Beta
67.01%ROE
72.38052wk Low
1.82%Amplitude
70.29%Gross Margin
32.73BMarket Cap
-1.90Reward/Risk
1.61%Risk Rate
TradingKey Stock Score of Zoetis Inc
Currency: USD Updated: 2026-07-16Key Insights
Zoetis Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 26 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 113.95.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Zoetis Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
37°C
Very Low
Very High
Negative
Zoetis Inc Highlights
StrengthsRisks
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.66%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.66%.
Undervalued
The company’s latest PE is 12.73, at a low 3-year percentile range.
Held by Ruane Cunniff
Star Investor Ruane Cunniff holds 3.59M shares of this stock.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
113.947
Target Price
+51.14%
Upside Space
Earnings Forecast
Analyst Rating
Based on
20
analysts
Buy
Current Rating
113.947
Target Price
+51.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Zoetis Inc
ZTS
20
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
36
Indicators
Moving Average
Indicators
Value
Direction
MA5
75.292
Buy
MA10
75.315
Buy
MA20
75.574
Buy
MA50
78.990
Sell
MA100
99.260
Sell
MA200
114.214
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Zoetis Inc Info
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Ticker SymbolZTS
CompanyZoetis Inc
CEOPeck (Kristin C)
Websitehttps://www.zoetis.com/
Shareholders
Related Instruments
+0.29%
+1.98%
+0.24%
+1.95%
+2.30%
+1.47%
+1.50%
+2.45%
-0.60%
+1.79%
+2.21%
+1.35%
+1.24%
-1.39%
+2.06%
0.00%
+1.30%
+1.31%
+2.30%
-0.36%Popular Instruments
52502.600
+4.900 (+0.01%)
28541.800
-439.400 (-1.52%)
7478.500
-46.600 (-0.62%)
14395.000
-446.000 (-3.00%)
64218.000
-1619.000 (-2.46%)
6217.700
-32.600 (-0.52%)
81.440
+2.161 (+2.73%)
333.920
+0.660 (+0.20%)
198.915
-8.485 (-4.09%)
3995.850
+20.290 (+0.51%)
FAQs
What is the current price of Zoetis Inc (ZTS)?
The current price of Zoetis Inc (ZTS) is 76.91.
What is the symbol of Zoetis Inc?
The ticker symbol of Zoetis Inc is ZTS.
What is the 52-week high of Zoetis Inc?
The 52-week high of Zoetis Inc is 172.23.
What is the 52-week low of Zoetis Inc?
The 52-week low of Zoetis Inc is 72.38.
What is the market capitalization of Zoetis Inc?
The market capitalization of Zoetis Inc is 32.24B.
Is Zoetis Inc (ZTS) currently rated as Buy, Hold, or Sell?
According to analysts, Zoetis Inc (ZTS) has an overall rating of Buy, with a price target of 113.95.
What is the Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS)?
The Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS) is 6.03.